Behaviours and attitudes influencing treatment decisions for menopausal symptoms in five European countries
- PMID: 26895640
- PMCID: PMC5019289
- DOI: 10.1177/2053369116632439
Behaviours and attitudes influencing treatment decisions for menopausal symptoms in five European countries
Abstract
Objective: To assess women's behaviours and attitudes regarding the treatment of menopausal symptoms in five European countries.
Study design: Women aged ≥45 years in France, Germany, Italy, Spain, and the United Kingdom participated in an internet survey. Completers were those who reported menopausal symptoms and had treated their symptoms. Women were equally stratified by age (45-54 years, 55-64 years, ≥65 years).
Main outcome measures: Behaviours, attitudes, and experiences regarding treatment of menopausal symptoms.
Results: Of 3890 peri- to postmenopausal women screened, 67% experienced symptoms and 54% sought either medical input or some treatment concerning their symptoms. Hot flushes, the most common symptom, decreased with age but remained prevalent after age 64. Roughly 75% of women who sought relief consulted a physician, mostly a gynaecologist or a general practitioner (GP) as in the United Kingdom. The decision to seek treatment was influenced by age, number, and severity of symptoms. Approximately 79% visiting a physician received prescription therapy. Of the women who received non-hormone therapy (HT) treatment instead of HT: patients refused HT (20-44%), physicians did not discuss HT (32-46%), or advised against HT (24-43%). Women in the United Kingdom were most familiar with and favorable to HT. Interest in a new HT (34-50%) was higher than use (19-28%).
Conclusions: Menopausal symptoms are common, persistent, and bothersome, but many fail to seek treatment. Sources and types of treatment vary among age groups and countries. Education regarding women's attitudes toward treatment should be provided to those physicians who treat menopausal symptoms in each country.
Keywords: Attitude; hormone therapy; menopause; survey; vasomotor symptoms.
© The Author(s) 2016.
Figures




Similar articles
-
Prevalence and opinions of hormone therapy prior to the Women's Health Initiative: a multinational survey on four continents.J Womens Health (Larchmt). 2008 Sep;17(7):1151-66. doi: 10.1089/jwh.2007.0584. J Womens Health (Larchmt). 2008. PMID: 18774896
-
Women's perception of sexuality around the menopause: outcomes of a European telephone survey.Eur J Obstet Gynecol Reprod Biol. 2008 Mar;137(1):10-6. doi: 10.1016/j.ejogrb.2006.10.036. Epub 2007 Jan 4. Eur J Obstet Gynecol Reprod Biol. 2008. PMID: 17207567
-
The dilemma of menopause and hormone replacement--a challenge for women and health-care providers: knowledge of menopause and hormone therapy in Spanish menopausal women.Climacteric. 2006 Oct;9(5):380-7. doi: 10.1080/13697130600955385. Climacteric. 2006. PMID: 17000585
-
Demographic characteristics and medical aspects of menopausal women in Taiwan.J Formos Med Assoc. 1997 Oct;96(10):806-11. J Formos Med Assoc. 1997. PMID: 9343980 Review.
-
Hormone therapy for the management of menopausal symptoms: pharmacotherapy update.J Pharm Pract. 2010 Dec;23(6):540-7. doi: 10.1177/0897190009360061. Epub 2010 Apr 8. J Pharm Pract. 2010. PMID: 21507860 Review.
Cited by
-
Vaginal Vitamin E for Treatment of Genitourinary Syndrome of Menopause: A Systematic Review of Randomized Controlled Trials.J Menopausal Med. 2022 Apr;28(1):9-16. doi: 10.6118/jmm.21028. J Menopausal Med. 2022. PMID: 35534426 Free PMC article. Review.
-
Women's Quality of Life in Menopause with a Focus on Hypertension.J Obstet Gynaecol India. 2019 Jun;69(3):279-283. doi: 10.1007/s13224-018-1172-y. Epub 2018 Oct 11. J Obstet Gynaecol India. 2019. PMID: 31178645 Free PMC article.
-
Non-hormonal strategies for managing menopausal symptoms in cancer survivors: an update.Ecancermedicalscience. 2019 Mar 11;13:909. doi: 10.3332/ecancer.2019.909. eCollection 2019. Ecancermedicalscience. 2019. PMID: 31123492 Free PMC article. Review.
-
Exit Interviews Examining Changes to Mood and Work/Productivity Impacts Related to Vasomotor Symptoms: Perspectives of Postmenopausal Women Receiving Elinzanetant in Phase III Clinical Trials.Patient. 2025 Jul 12. doi: 10.1007/s40271-025-00748-4. Online ahead of print. Patient. 2025. PMID: 40650860
-
Prevalence and impact of vasomotor symptoms associated with menopause among Nordic women: Subgroup analysis from an international cross-sectional survey.Acta Obstet Gynecol Scand. 2025 Aug;104(8):1575-1586. doi: 10.1111/aogs.15139. Epub 2025 May 1. Acta Obstet Gynecol Scand. 2025. PMID: 40312875 Free PMC article.
References
-
- Hunter MS, Gentry-Maharaj A, Ryan A, et al. Prevalence, frequency and problem rating of hot flushes persist in older postmenopausal women: Impact of age, body mass index, hysterectomy, hormone therapy use, lifestyle and mood in a cross-sectional cohort study of 10,418 British women aged 54–65. BJOG 2012; 119: 40–50. - PubMed
-
- Buhling KJ, Daniels BV, Studnitz FS, et al. The use of complementary and alternative medicine by women transitioning through menopause in Germany: Results of a survey of women aged 45–60 years. Complement Ther Med 2014; 22: 94–98. - PubMed
-
- Garton M, Reid D, Rennie E. The climacteric, osteoporosis and hormone replacement; views of women aged 45-49. Maturitas 1995; 21: 7–15. - PubMed
-
- van Geelen JM, van de Weijer PH, Arnolds HT. Urogenital symptoms and resulting discomfort in non-institutionalized Dutch women aged 50–75 years. Int Urogynecol J Pelvic Floor Dysfunct 2000; 11: 9–14. - PubMed
-
- Nappi RE, Kokot-Kierepa M. Women’s voices in the menopause: Results from an international survey on vaginal atrophy. Maturitas 2010; 67: 233–238. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical